Proactive Investors - Run By Investors For Investors

Abcam given boost by rabbit antibody

China was a trail-blazer as its turnover grew just short of 30%.
Abcam given boost by rabbit antibody
What's up Doc? RabMAb, a suite of rabbit monoclonal antibodies, was in huge demand

Abcam PLC (LON:ABC), one of the world’s largest suppliers of antibodies used in research, said revenue and gross profit margins were in line with market forecasts.

Catalogue sales growth was 10.7% in the first half of the Cambridge group’s financial year with RabMAb, a suite of rabbit monoclonal antibodies, in huge demand.

China was a trail-blazer as its turnover grew just short of 30%.

For the year, Abcam expects turnover to increase by 10% on a constant currency basis and 30.4% on a reported basis. 

"We have maintained revenue momentum delivering more than twice market revenue growth in the period,” said chief executive Alan Hirzel.

“Our award-winning web site, unique products and fast service enable Abcam to better serve researchers to achieve their mission faster.

“Overall, we continue to make good progress against our strategic and investment objectives and continue to see growth opportunities for Abcam."

View full ABC profile View Profile

Abcam Timeline

January 10 2017

Related Articles

scientist in laboratory
May 24 2019
Here we take a closer look at healthcare investor NetScientific PLC (LON:NSCI)
Callitas CEO James Thompson
July 20 2018
CannaStrips will generate near-term revenue, while the company’s blue-sky pharmaceutical assets and orphan drug are solid, long-term plays
lung x-ray
May 07 2019
The company has been developing a treatment for chronic lung disease in-house and has partnered with an Australian group to develop a drug for rare liver and lung complaints

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use